GlassScriptPhysician profile
Young Min Cho
NPI 1558821959
$1,643.89
in general payments reported to CMS, 2019-2025
16 companies · $988 in 2025
The $988 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $36.00 · 2024: $620 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,634 · Education: $9.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,634.24 |
| Education | $9.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $533.97 | 2024-2025 | Tavneos, Evenity, Otezla |
| Ucb, INC. | $184.45 | 2025 | Bimzelx |
| Astrazeneca Pharmaceuticals LP | $167.65 | 2024 | Saphnelo |
| Mallinckrodt Hospital Products INC. | $154.84 | 2024-2025 | Acthar, Terlivaz |
| Abbvie INC. | $148.66 | 2025 | |
| Novartis Pharmaceuticals Corporation | $89.81 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.73 | 2023-2025 | Ofev, Jardiance |
| Merck Sharp & Dohme LLC | $54.07 | 2024-2025 | Zerbaxa |
| Pfizer INC. | $43.74 | 2025 | |
| United Therapeutics Corporation | $41.29 | 2025 | |
| Sobi, INC | $40.36 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $29.42 | 2025 | Orencia |
| Stryker Corporation | $25.00 | 2024 | Adherus Autospray Et Dural Sealant, Duramatrix, Universal Neuro 3 |
| Pacira Pharmaceuticals Incorporated | $16.17 | 2024 | Zilretta |
| Abbott Laboratories | $15.36 | 2025 | Freestyle Libre 3 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $14.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Young Min Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.